-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LZS7AqR2/cAfaArw3vxc0wCRioLRGZ3ADjwflD+8oNZ+caZlxAYSdKazFy6UOqaX XA1Ow7svp6xUc+EsDSfjkA== 0000736822-96-000004.txt : 19960213 0000736822-96-000004.hdr.sgml : 19960213 ACCESSION NUMBER: 0000736822-96-000004 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 19960212 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IMMUCOR INC CENTRAL INDEX KEY: 0000736822 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 222408354 STATE OF INCORPORATION: GA FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-37473 FILM NUMBER: 96515595 BUSINESS ADDRESS: STREET 1: 3130 GATEWAY DR STREET 2: PO BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091 BUSINESS PHONE: 4044412051 MAIL ADDRESS: STREET 1: 3130 GATEWAY DR STREET 2: P O BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WILMS JOSEF CENTRAL INDEX KEY: 0000937311 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: P O BOX 5625 STREET 2: 3130 GATEWAY DRIVE CITY: NURCROSS STATE: GA ZIP: 30091 BUSINESS PHONE: 7704412051 MAIL ADDRESS: STREET 1: P O BOX STREET 2: 3130 GATEWAY DRIVE CITY: NORCROSS STATE: GA ZIP: 30091-5625 SC 13G/A 1 SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) IMMUCOR, INC. (Name of Issuer) Common (Title of Class of Securities) 452526-10-6-10 (CUSIP Number) Check the following box if a fee is being paid with this statement /_/. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). SCHEDULE 13G CUSIP No. 452526-10-6-10 1. Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Josef Wilms 2. Check the Appropriate Box if a Member of a Group (a) /_/ (b) /_/ 3. SEC Use Only 4. Citizenship or Place of Organization Federal Republic of Germany Number of Shares Beneficially Owned By Each Reporting Person With 5. Sole Voting Power 333,000 6. Shared Voting Power None 7. Sole Dispositive Power 333,000 8. Shared Dispositive Power None 9. Aggregate Amount Beneficially Owned by Each Reporting Person 333,000 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares /_/ 11. Percent of Class Represented by Amount in Row 9 4.04% 12. Type of Reporting Person IN Schedule 13G - Amendment No. 1 The undersigned hereby amends the statement on Schedule 13G, dated February 1, 1995, filed by the undersigned, relating to the shares of Common Stock, par value of $.10 per share of Immucor, Inc., as set forth below. Item 4. Ownership (a) Amount Beneficially Owned Josef Wilms is the beneficial owner of warrants to purchase 243,750 shares of Common Stock at an exercise price of $7.75, and options to acquire 89,250 shares of Common Stock at an exercise price of $9.33. (b) Percent of Class 4.04% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 333,000 (ii) sole power to dispose or the direct the disposition of: 333,000 Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following box /X/. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 12, 1996 Date /s/ Josef Wilms Signature Josef Wilms, President, Immucor GmbH Name/Title EX-99 2 EXHIBIT 99 - Restatement of Original Schedule 13G Previously Filed in Paper Form SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. __ ) IMMUCOR, INC. (Name of Issuer) Common (Title of Class of Securities) 452526-10-6-10 (CUSIP Number) Check the following box if a fee is being paid with this statement /X/. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). SCHEDULE 13G CUSIP No. 452526-10-6-10 1. Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Josef Wilms 2. Check the Appropriate Box if a Member of a Group (a) /_/ (b) /_/ 3. SEC Use Only 4. Citizenship or Place of Organization Federal Republic of Germany Number of Shares Beneficially Owned By Each Reporting Person With 5. Sole Voting Power 408,000 6. Shared Voting Power None 7. Sole Dispositive Power 408,000 8. Shared Dispositive Power None 9. Aggregate Amount Beneficially Owned by Each Reporting Person 408,000 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares /_/ 11. Percent of Class Represented by Amount in Row 9 5.0% 12. Type of Reporting Person IN Item 1. (a) Name of Issuer Immucor, Inc. (b) Address of Issuer's Principal Executive Offices 3130 Gateway Drive Post Office Box 5625 Norcross, Georgia 30091-5625 Item 2. (a) Name of Person Filing Josef Wilms (b) Address of Principal Business Office or, if none, Residence Immucor Medizinische Diagnostik GmbH Postfach 200247 D-63308 Rodermark Adam Opel Strasse 26 D-63322 Rodermark (c) Citizenship Federal Republic of Germany (d) Title of Class of Securities Common Stock (e) CUSIP Number Inapplicable Item 3. Inapplicable. Item 4. Ownership (a) Amount Beneficially Owned Josef Wilms is the beneficial owner of warrants to purchase 318,750 shares of Common Stock at an exercise price of $7.75, and options to acquire 89,250 shares of Common Stock at an exercise price of $9.33. (b) Percent of Class 5.0% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 408,000 (iii) sole power to dispose or to direct the disposition of: 408,000 Item 5. Ownership of Five Percent or Less of a Class Inapplicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person Inapplicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Inapplicable. Item 8. Identification and Classification of Members of the Group Inapplicable. Item 9. Notice of Dissolution of Group Inapplicable. Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 1, 1995 Date /s/ Josef Wilms Signature Josef Wilms, President Name/Title -----END PRIVACY-ENHANCED MESSAGE-----